STI
36
3
GLW
52
3
BAX
35
3
MTCH
57
6
CTSH
54
2
PH
73
3
KEY
39
6
BBY
56
4
JBHT
50
5
CMG
57
-3
LH
42
6
NOV
53
-2
NAVI
47
6
NVDA
61
5
HSIC
50
2
NI
67
2
INTC
47
4
MCHP
51
6
WDC
41
3
ALLE
35
3
STI
36
3
GLW
52
3
BAX
35
3
MTCH
57
6
CTSH
54
2
PH
73
3
KEY
39
6
BBY
56
4
JBHT
50
5
CMG
57
-3
LH
42
6
NOV
53
-2
NAVI
47
6
NVDA
61
5
HSIC
50
2
NI
67
2
INTC
47
4
MCHP
51
6
WDC
41
3
ALLE
35
3
Financhill
Back

BCB Bancorp Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
23

BCBP
BCB Bancorp

Last Price:
$10.41
Seasonality Move:
-2.66%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$105.33
Seasonality Move:
1.75%
Sell
23
BCB Bancorp (BCBP) is a Sell

Is BCB Bancorp a Buy, Sell or Hold?

  • The current BCB Bancorp [BCBP] share price is $10.34. The Score for BCBP is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • BCBP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BCBP Stock Price Chart

What is BCB Bancorp's stock price today?

  • The BCB Bancorp share price today is $10.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCBP is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

BCBP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.38 Sell
Relative Strength Index (14 RSI): 35.27 Sell
Chaikin Money Flow: -12525 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.56 - 11.64) Sell
Bollinger Bands (100): (11.27 - 12.93) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

BCBP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.56 Sell
20-day SMA: 11.04 Sell
50-day SMA: 11.64 Sell
200-day SMA: 11.58 Sell
8-day EMA: 10.53 Sell
20-day EMA: 10.9 Sell
50-day EMA: 11.45 Sell
200-day EMA: 11.74 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

BCB Bancorp Earnings Growth & BCBP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.06 per share, and an increase next year of $0.44 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

BCB Bancorp Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):